Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Convertible Debt (2016 - 2017)

Lexaria Bioscience's Convertible Debt history spans 2 years, with the latest figure at $45000.0 for Q2 2017.

  • For Q2 2017, Convertible Debt changed 0.0% year-over-year to $45000.0; the TTM value through May 2017 reached $45000.0, changed 0.0%, while the annual FY2016 figure was $45000.0, N/A changed from the prior year.
  • Convertible Debt for Q2 2017 was $45000.0 at Lexaria Bioscience, roughly flat from $45000.0 in the prior quarter.
  • Across five years, Convertible Debt topped out at $45000.0 in Q2 2016 and bottomed at $45000.0 in Q2 2016.